Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
Study sponsor: Anika Therapeutics, Inc. · ANIK
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-05-16Actual
Enrollment · participants231Actual
Source updated2023-08-09Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.